Skip to main content
Clinical Trials/CTRI/2022/10/046357
CTRI/2022/10/046357Not yet recruitingNot Applicable

Comparison of two different doses of hyperbaric ropivacaine in spinal anaesthesia for infraumbilical surgeries- a randomized controlled trial.

Dr Prashant Atmaram Lomate1 site in 1 country120 target enrollmentStarted: October 20, 2022Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
120
Locations
1
Primary Endpoint
duration of analgesia after 2cc and 2.4cc volumes of 0.75% hyperbaric ropivacaine when given for spinal anaesthesia during infraumbilical surgeries.

Study Overview

Brief Summary

the proposed RCT comparing the efficacy of two different volumes of 0.75% hyperbaric ropivacaine for spinal anaesthesia in infraumbilical surgeries is innovative. the primary and secondary outcomes of the study are expected to add greatly to the understanding of the ideal drug volume of inj ropivacaine. the central hypothesis of the proposed research is that the quality of spinal anaesthesia in terms of duration oof analgesia;and onset and offset times of sensory-motor blockade will be better with 2.4cc than 2cc of 0.75% hyperbaric ropivacaine during infraumbilical surgeries under spinal anaesthesia.

Study Design

Study Type
Interventional
Allocation
Computer generated randomization
Masking
Participant, Investigator and Outcome Assessor Blinded

Eligibility Criteria

Ages
18.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • 1.ASA grade I or grade II patients 2.Either sex 3.Age- 18 to 60 years 4.Scheduled for elective infraumbilical surgeries under spinal anaesthesia.

Exclusion Criteria

  • 1.Patient refusal to participate in the study.
  • 2.Known hypersensitivity to local anaesthetics 3.Bleeding disorders 4.Anatomic abnormality of spine 5.Severe systemic diseases 6.Pregnant patients.

Outcomes

Primary Outcomes

duration of analgesia after 2cc and 2.4cc volumes of 0.75% hyperbaric ropivacaine when given for spinal anaesthesia during infraumbilical surgeries.

Time Frame: duration of analgesia- assesses for 24 hours.

Secondary Outcomes

  • 1.onset times of sensory and motor block.(2.duration of sensory and motor block)

Investigators

Sponsor
Dr Prashant Atmaram Lomate
Sponsor Class
Other [self]

Study Sites (1)

Loading locations...

Similar Trials